The immunology of multiple sclerosis

[1]  Mark S. Anderson,et al.  Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM , 2022, Nature.

[2]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[3]  A. Waisman,et al.  Antigen-presenting innate lymphoid cells orchestrate neuroinflammation , 2021, Nature.

[4]  F. Ginhoux,et al.  Repositioning TH cell polarization from single cytokines to complex help , 2021, Nature Immunology.

[5]  F. Piehl,et al.  Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies. , 2021, JAMA neurology.

[6]  M. Cairns,et al.  Advancing the use of genome-wide association studies for drug repurposing , 2021, Nature Reviews Genetics.

[7]  F. Quintana,et al.  Functional immune cell–astrocyte interactions , 2021, The Journal of experimental medicine.

[8]  W. Han,et al.  Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models , 2021, Immunology.

[9]  K. Gibson-Corley,et al.  Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis , 2021, Science Advances.

[10]  Maxim N. Artyomov,et al.  Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders , 2021, Science.

[11]  Jasmin Herz,et al.  Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma , 2021, Science.

[12]  A. Bar-Or,et al.  B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies , 2021, Nature Reviews Neurology.

[13]  B. Hall,et al.  Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells , 2021, Scientific Reports.

[14]  V. Buchholz,et al.  Skin and gut imprinted T helper cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity , 2021, Nature Immunology.

[15]  A. Abate,et al.  Barcoded viral tracing of single-cell interactions in central nervous system inflammation , 2021, Science.

[16]  G. Krishnamoorthy,et al.  High-salt diet suppresses autoimmune demyelination by regulating the blood–brain barrier permeability , 2021, Proceedings of the National Academy of Sciences.

[17]  L. Fugger,et al.  Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis , 2021, Med.

[18]  D. Busch,et al.  Formation and immunomodulatory function of meningeal B-cell aggregates in progressive CNS autoimmunity. , 2021, Brain : a journal of neurology.

[19]  R. Duvoisin,et al.  Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation , 2021, The Journal of experimental medicine.

[20]  D. Booth,et al.  The Interaction of Human and Epstein–Barr Virus miRNAs with Multiple Sclerosis Risk Loci , 2021, International journal of molecular sciences.

[21]  G. D. Di Liberto,et al.  Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling , 2021, Nature Communications.

[22]  M. Simons,et al.  Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination , 2021, Nature Metabolism.

[23]  A. Rokas,et al.  The influence of evolutionary history on human health and disease , 2021, Nature Reviews Genetics.

[24]  S. Mostafavi,et al.  Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes. , 2020, Nature immunology.

[25]  M. Rydzanicz,et al.  Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics , 2020, PloS one.

[26]  J. Gommerman,et al.  Regulation of neuroinflammation by B cells and plasma cells , 2020, Immunological reviews.

[27]  Nora C. Toussaint,et al.  HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis , 2020, Cell.

[28]  V. Apostolopoulos,et al.  Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab , 2020, Brain sciences.

[29]  Shaohui Wang,et al.  Type 2 Innate Lymphoid Cells Induce CNS Demyelination in an HSV-IL-2 Mouse Model of Multiple Sclerosis , 2020, iScience.

[30]  Melanie J. Plastini,et al.  Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis , 2020, Frontiers in Cellular Neuroscience.

[31]  K. Pahan,et al.  IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE , 2020, Proceedings of the National Academy of Sciences.

[32]  R. Spain,et al.  Lipoic acid modulates inflammatory responses of monocytes and monocyte‐derived macrophages from healthy and relapsing‐remitting multiple sclerosis patients , 2020, Immunology and cell biology.

[33]  S. Nutt,et al.  Transcriptional Networks Driving Dendritic Cell Differentiation and Function. , 2020, Immunity.

[34]  M. Sinyuk,et al.  The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome , 2020, Journal of Neuroinflammation.

[35]  T. Speed,et al.  Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells , 2020, Life Science Alliance.

[36]  T. Kuhlmann,et al.  Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. , 2020, Brain : a journal of neurology.

[37]  J. Harty,et al.  Peripherally induced brain tissue-resident memory CD8+ T cells mediate protection against CNS infection , 2020, Nature Immunology.

[38]  I. Amit,et al.  Cxcl10+ monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation , 2020, Nature Immunology.

[39]  J. Trojanowski,et al.  Protein transmission in neurodegenerative disease , 2020, Nature Reviews Neurology.

[40]  J. Cuzick,et al.  Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors , 2020, Multiple sclerosis.

[41]  M. Scholz,et al.  Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism , 2020, Cell.

[42]  Martina Kunkl,et al.  T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis , 2020, Cells.

[43]  J. Ragoussis,et al.  MAFG-driven astrocytes promote CNS inflammation , 2020, Nature.

[44]  N. Esmaeil,et al.  Evaluation of the effect of GM-CSF blocking on the phenotype and function of human monocytes , 2020, Scientific Reports.

[45]  G. Stewart,et al.  The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis , 2020, Scientific Reports.

[46]  B. Healy,et al.  Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis. , 2020, JAMA neurology.

[47]  D. Reich,et al.  Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo. , 2019, JAMA neurology.

[48]  F. Sellebjerg,et al.  MAIT cell subtypes in multiple sclerosis , 2019, Journal of Neuroimmunology.

[49]  J. Correale,et al.  Mucosal-Associated Invariant T Cell Features and TCR Repertoire Characteristics During the Course of Multiple Sclerosis , 2019, Front. Immunol..

[50]  D. Reich,et al.  Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease , 2019, bioRxiv.

[51]  Dunfang Zhang,et al.  High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-β Cytokine Activation. , 2019, Immunity.

[52]  J. Goverman,et al.  Pathogenic T cell cytokines in multiple sclerosis , 2019, The Journal of experimental medicine.

[53]  Steffen Jung,et al.  Microglia Biology: One Century of Evolving Concepts , 2019, Cell.

[54]  Simon C. Potter,et al.  Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.

[55]  Knut K. Kolskår,et al.  Common brain disorders are associated with heritable patterns of apparent aging of the brain , 2019, Nature Neuroscience.

[56]  C. Larminie,et al.  Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines , 2019, Nature Communications.

[57]  D. Arnold,et al.  Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis , 2019, Brain : a journal of neurology.

[58]  Maria Hortlund,et al.  Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis , 2019, bioRxiv.

[59]  Mark M. Davis,et al.  Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis , 2019, Nature.

[60]  J. van de Peppel,et al.  Human Memory Th17 Cell Populations Change Into Anti-inflammatory Cells With Regulatory Capacity Upon Exposure to Active Vitamin D , 2019, Front. Immunol..

[61]  B. Becher,et al.  GM-CSF and CXCR4 Define a T Helper Cell Signature in Multiple Sclerosis , 2019, Nature Medicine.

[62]  E. Gundelfinger,et al.  Bassoon proteinopathy drives neurodegeneration in multiple sclerosis , 2019, Nature Neuroscience.

[63]  O. Ciccarelli,et al.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines , 2019, Brain : a journal of neurology.

[64]  H. Lassmann,et al.  Communication of CD8+ T cells with mononuclear phagocytes in multiple sclerosis , 2019, Annals of clinical and translational neurology.

[65]  Richard Reynolds,et al.  Neuronal vulnerability and multilineage diversity in multiple sclerosis , 2019, Nature.

[66]  Qi Wan,et al.  NKT Cells in Neurological Diseases , 2019, Front. Cell. Neurosci..

[67]  Till F. M. Andlauer,et al.  A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis , 2019, Nature Communications.

[68]  T. Olsson,et al.  Lifestyle and Environmental Factors in Multiple Sclerosis. , 2019, Cold Spring Harbor perspectives in medicine.

[69]  Johannes U. Mayer,et al.  Single-Cell Analysis of Diverse Pathogen Responses Defines a Molecular Roadmap for Generating Antigen-Specific Immunity. , 2019, Cell systems.

[70]  M. Oukka,et al.  Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells , 2019, Front. Immunol..

[71]  D. Arnold,et al.  Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis , 2019, Brain : a journal of neurology.

[72]  D. Hafler,et al.  TIGIT signaling restores suppressor function of Th1 Tregs. , 2019, JCI insight.

[73]  Sagar,et al.  Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution , 2019, Nature.

[74]  S. Kügler,et al.  β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration , 2019, Nature.

[75]  B. Becher,et al.  Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation , 2019, Science Immunology.

[76]  J. Lechner-Scott,et al.  Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis , 2019, JAMA.

[77]  Jacob F. Degner,et al.  Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval , 2019, bioRxiv.

[78]  A. Bar-Or,et al.  Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 , 2019, Cell.

[79]  R. Reynolds,et al.  Meningeal inflammation and cortical demyelination in acute multiple sclerosis , 2018, Annals of neurology.

[80]  Makoto Tsuda,et al.  Transcription factor MafB contributes to the activation of spinal microglia underlying neuropathic pain development , 2018, Glia.

[81]  E. Remmerswaal,et al.  Tissue-resident memory T cells populate the human brain , 2018, Nature Communications.

[82]  A. Mildner,et al.  Developmental and Functional Heterogeneity of Monocytes. , 2018, Immunity.

[83]  T. Noda,et al.  Activated β-Catenin in Foxp3+ Regulatory T cells Links Inflammatory Environments to Autoimmunity , 2018, Nature Immunology.

[84]  Alexander R. Pico,et al.  Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration , 2018, Nature Immunology.

[85]  J. Álvarez-cermeño,et al.  Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile , 2018, Multiple sclerosis.

[86]  Ludwig Kappos,et al.  Neurofilaments as biomarkers in neurological disorders , 2018, Nature Reviews Neurology.

[87]  N. Yosef,et al.  Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis , 2018, Nature Communications.

[88]  M. Simons,et al.  Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model , 2018, Nature Neuroscience.

[89]  R. Locksley,et al.  Innate Lymphoid Cells: 10 Years On , 2018, Cell.

[90]  Eyal David,et al.  Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone‐induced demyelination , 2018, European journal of immunology.

[91]  H. Lassmann,et al.  The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells , 2018, Brain : a journal of neurology.

[92]  G. Weinstock,et al.  Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. , 2018, Cell metabolism.

[93]  B. Pakkenberg,et al.  Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex , 2018, Neuropathology and applied neurobiology.

[94]  T. Akaishi,et al.  Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis , 2018, Journal of Neuroimmunology.

[95]  R. Hupperts,et al.  Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients , 2018, Scientific Reports.

[96]  Marco Prinz,et al.  Microglial control of astrocytes in response to microbial metabolites , 2018, Nature.

[97]  H. Atkins,et al.  Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis , 2018, Front. Immunol..

[98]  Yuanjie Sun,et al.  T Follicular Helper-Like Cells Are Involved in the Pathogenesis of Experimental Autoimmune Encephalomyelitis , 2018, Front. Immunol..

[99]  G. Freeman,et al.  Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function , 2018, The Journal of Immunology.

[100]  H. Lassmann.  Multiple Sclerosis Pathology. , 2018, Cold Spring Harbor perspectives in medicine.

[101]  R. Ko,et al.  Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation , 2018, Front. Immunol..

[102]  Bo Peng,et al.  Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion , 2018, Nature Neuroscience.

[103]  M. Friese,et al.  Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression , 2018, The Journal of Immunology.

[104]  Melissa A Brown,et al.  Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility , 2018, Proceedings of the National Academy of Sciences.

[105]  C. Fagnani,et al.  Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis , 2018, Journal of Neuroinflammation.

[106]  A. L. La Flamme,et al.  Innate IFN-γ ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression , 2018, Scientific Reports.

[107]  Yan Kang,et al.  Tregs: Where We Are and What Comes Next? , 2017, Front. Immunol..

[108]  Sean M. Kearney,et al.  Salt-responsive gut commensal modulates TH17 axis and disease , 2017, Nature.

[109]  Arash Pourgholaminejad,et al.  The role of Th17 cells in auto-inflammatory neurological disorders , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[110]  J. Lechner-Scott,et al.  Natural killer cell subpopulations are associated with MRI activity in a relapsing-remitting multiple sclerosis patient cohort from Australia , 2017, Multiple sclerosis.

[111]  Nicholas C. Firth,et al.  Progression of regional grey matter atrophy in multiple sclerosis , 2017, bioRxiv.

[112]  K. Berer,et al.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice , 2017, Proceedings of the National Academy of Sciences.

[113]  A. Bar-Or,et al.  B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro , 2017, Journal of Neuroimmunology.

[114]  K. Magori,et al.  A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis , 2017, Gut microbes.

[115]  R. Perera,et al.  Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex , 2017, Annals of neurology.

[116]  J. Flickinger,et al.  T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation , 2017, Nature Immunology.

[117]  A. Langerak,et al.  Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients , 2017, Acta Neuropathologica.

[118]  S. McColl,et al.  IL-17-producing γδ T cells switch migratory patterns between resting and activated states , 2017, Nature Communications.

[119]  Joana Dias,et al.  Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines , 2017, Proceedings of the National Academy of Sciences.

[120]  B. Becher,et al.  Dysregulation of the Cytokine GM‐CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System , 2017, Immunity.

[121]  T. Korn,et al.  Dendritic cells in central nervous system autoimmunity , 2017, Seminars in Immunopathology.

[122]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[123]  J. Burrows,et al.  Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis , 2017, Clinical & translational immunology.

[124]  S. Jarius,et al.  Myeloid dendritic cells exhibit defects in activation and function in patients with multiple sclerosis , 2016, Journal of Neuroimmunology.

[125]  A. Cossarizza,et al.  iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles , 2016, Front. Immunol..

[126]  Adam R. Johnson,et al.  Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity , 2016, Science Translational Medicine.

[127]  E. Coccia,et al.  Interferon‐β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS‐mediated apoptosis , 2016, Immunology and cell biology.

[128]  S. Gold,et al.  Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis , 2016, Neuroscience & Biobehavioral Reviews.

[129]  T. Korn,et al.  Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection , 2016, The Journal of experimental medicine.

[130]  T. Olsson,et al.  Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins , 2016, Proceedings of the National Academy of Sciences.

[131]  R. Hohlfeld,et al.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation , 2016, Proceedings of the National Academy of Sciences.

[132]  S. Nedellec,et al.  Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis. , 2016, Clinical immunology.

[133]  N. Pochet,et al.  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the aryl hydrocarbon receptor , 2016, Nature Medicine.

[134]  D. Lodygin,et al.  Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid , 2016, Nature.

[135]  A. Awasthi,et al.  The Emerging Roles of Gamma–Delta T Cells in Tissue Inflammation in Experimental Autoimmune Encephalomyelitis , 2016, Front. Immunol..

[136]  J. Correale,et al.  Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses , 2015, Cell.

[137]  Calliope A. Dendrou,et al.  Class II HLA interactions modulate genetic risk for multiple sclerosis , 2015, Nature Genetics.

[138]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[139]  C. Clish,et al.  Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.

[140]  E. Rodríguez-Martín,et al.  Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis , 2015, Clinical and experimental immunology.

[141]  M. Z. Cader,et al.  EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy , 2015, PloS one.

[142]  E. Granieri,et al.  Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study , 2015, Multiple sclerosis.

[143]  M. Friese,et al.  CD8+ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL‐18 serum levels in multiple sclerosis , 2014, European journal of immunology.

[144]  M. Sirota,et al.  Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis , 2014, Science Translational Medicine.

[145]  Steven H. Kleinstein,et al.  B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes , 2014, Science Translational Medicine.

[146]  X. Montalban,et al.  Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis , 2014, Annals of neurology.

[147]  Simon A. Jones,et al.  Ectopic lymphoid-like structures in infection, cancer and autoimmunity , 2014, Nature Reviews Immunology.

[148]  M. Rovaris,et al.  Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study , 2014, Multiple sclerosis.

[149]  A. Goris,et al.  HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients , 2014, Multiple sclerosis.

[150]  S. Burrows,et al.  Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis , 2014, Multiple sclerosis.

[151]  E. Frohman,et al.  Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells. , 2014, Clinical immunology.

[152]  Manuel A. Friese,et al.  Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis , 2014, Nature Reviews Neurology.

[153]  H. Goossens,et al.  Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors , 2014, Multiple sclerosis.

[154]  A. Vanderver,et al.  Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases , 2014, The Journal of Immunology.

[155]  A. Lew,et al.  GM-CSF–Responsive Monocyte-Derived Dendritic Cells Are Pivotal in Th17 Pathogenesis , 2014, The Journal of Immunology.

[156]  M. Mirabella,et al.  Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis , 2013, Journal of Neuroimmunology.

[157]  P. Calabresi,et al.  Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. , 2013, Brain : a journal of neurology.

[158]  J. Trowsdale,et al.  Natural killer cells and their receptors in multiple sclerosis. , 2013, Brain : a journal of neurology.

[159]  E. Granieri,et al.  Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation , 2013, Journal of Neuroimmune Pharmacology.

[160]  B. Hemmer,et al.  Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis. , 2013, JAMA neurology.

[161]  J. Goverman,et al.  MHC Class I-Restricted Myelin Epitopes Are Cross-Presented by Tip-DCs That Promote Determinant Spreading to CD8+ T Cells , 2013, Nature Immunology.

[162]  R. Reynolds,et al.  Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. , 2012, Brain : a journal of neurology.

[163]  V. Yong,et al.  Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. , 2012, The American journal of pathology.

[164]  Calliope A. Dendrou,et al.  TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis , 2012, Nature.

[165]  J. Parratt,et al.  Oligodendrocytes and the early multiple sclerosis lesion , 2012, Annals of neurology.

[166]  Xiangpei Li,et al.  CD4+CD25+CD127low/− T Cells: A More Specific Treg Population in Human Peripheral Blood , 2012, Inflammation.

[167]  A. Bar-Or,et al.  Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro , 2012, Journal of Neuroimmunology.

[168]  B. Ursø,et al.  Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A , 2012, PloS one.

[169]  T. Olsson,et al.  High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women , 2012, Multiple sclerosis.

[170]  X. Montalban,et al.  Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. , 2011, Clinical immunology.

[171]  P. D. Jager,et al.  Genome-wide association study of severity in multiple sclerosis , 2011, Genes and Immunity.

[172]  K. Berer,et al.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.

[173]  C. Baecher-Allan,et al.  Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.

[174]  P. Calabresi,et al.  Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients , 2011, Journal of Neuroimmunology.

[175]  Nitin J. Karandikar,et al.  Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. , 2011, Journal of autoimmunity.

[176]  H. Weiner,et al.  Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis , 2010, Annals of neurology.

[177]  R. Reynolds,et al.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis , 2010, Annals of neurology.

[178]  G. Giovannoni,et al.  An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis , 2010, PloS one.

[179]  H. Wiendl,et al.  An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis , 2010, The Journal of Immunology.

[180]  M. Lynch,et al.  Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis , 2010, Brain, Behavior, and Immunity.

[181]  J. Lünemann,et al.  Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis , 2010, Annals of neurology.

[182]  D. Foureau,et al.  Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.

[183]  V. Kuchroo,et al.  New pieces in the puzzle: How does interferon‐β really work in multiple sclerosis? , 2009, Annals of neurology.

[184]  Irah L. King,et al.  Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. , 2009, Blood.

[185]  E. Hogan,et al.  T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to α-galactosylceramide are impaired , 2008, Journal of the Neurological Sciences.

[186]  A. Lutterotti,et al.  Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis , 2008, PloS one.

[187]  K. Venken,et al.  Compromised CD4+ CD25high regulatory T‐cell function in patients with relapsing‐remitting multiple sclerosis is correlated with a reduced frequency of FOXP3‐positive cells and reduced FOXP3 expression at the single‐cell level , 2008, Immunology.

[188]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[189]  D. Hafler,et al.  Abnormal Tr1 differentiation in multiple sclerosis , 2007, Journal of Neuroimmunology.

[190]  G. Gigli,et al.  Innate immunity modulates autoimmunity: type 1 interferon‐β treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation , 2007, Immunology.

[191]  J. Newcombe,et al.  CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions , 2007, Journal of Neuroimmunology.

[192]  L. Airas,et al.  Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta , 2007, Neurological Sciences.

[193]  Georg Schett,et al.  Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.

[194]  H. Harputluoglu,et al.  Rituximab-related viral infections in lymphoma patients , 2007, Leukemia & lymphoma.

[195]  G. Freeman,et al.  Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response1 , 2006, The Journal of Immunology.

[196]  M. Calabrese,et al.  Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. , 2006, Brain : a journal of neurology.

[197]  T. Yamamura,et al.  Invariant Vα19i T cells regulate autoimmune inflammation , 2006, Nature Immunology.

[198]  Nitin J. Karandikar,et al.  Therapeutic Induction of Regulatory, Cytotoxic CD8+ T Cells in Multiple Sclerosis1 , 2006, The Journal of Immunology.

[199]  R. Gold,et al.  Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. , 2006, Brain : a journal of neurology.

[200]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[201]  J. Newcombe,et al.  Accumulation of Vα7.2–Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system , 2004 .

[202]  S. Ludwin,et al.  High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. , 2003, The Journal of infectious diseases.

[203]  S. Miller,et al.  EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4 , 2022 .

[204]  J. Goverman,et al.  A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis , 2001, The Journal of experimental medicine.

[205]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[206]  Jan Engberg,et al.  Visualization of Myelin Basic Protein (Mbp) T Cell Epitopes in Multiple Sclerosis Lesions Using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (Hla)-Dr2–Mbp 85–99 Complex , 2000, The Journal of experimental medicine.

[207]  J. Newcombe,et al.  Differential Expression of NK T Cell Vα24JαQ Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy1 , 2000, The Journal of Immunology.

[208]  R. Shimonkevitz,et al.  Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[209]  Hong Jiang,et al.  Role of CD8+ T Cells in Murine Experimental Allergic Encephalomyelitis , 1992, Science.

[210]  Control of Regulatory T cell Stability, Plasticity and Function in Health and Disease , 2021, Frontiers Research Topics.

[211]  Hans Lassmann,et al.  An updated histological classification system for multiple sclerosis lesions , 2016, Acta Neuropathologica.

[212]  Michael Detmar,et al.  A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules , 2015 .

[213]  Jia Newcombe,et al.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.

[214]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[215]  J. Haines,et al.  CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis , 2000, Immunogenetics.

[216]  H. Lassmann,et al.  Animal models , 1994, Annals of neurology.